看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
$ o0 e6 x- b0 Z; B* m0 q: Z2 P: u* L. R9 |! X6 y( n" J
+ g1 L' k. _) B' h: h( J4 X
Currently available feasibility data for possible combination strategies.
% x3 y0 L1 u5 B$ w% i————————————————————————————————
) G% [. @& ]/ b; JCombination Feasibility according to preliminary data
4 p0 F" g* \* G# ~* L# A——————————————————————————————————
0 }0 {2 P- s* K: T9 h# iBevacizumab + sorafenib Yes, reduced dose 9 `8 B$ P+ y. R7 g
Bevacizumab + sunitinib† No
( @( p0 x" Y3 jBevacizumab + temsirolimus Yes 2 l7 v+ \6 @. @& l0 L! B% ]
Bevacizumab + everolimus Yes ! ~ t, J+ c7 a5 P
Sorafenib + sunitinib ?
& W& \7 @7 S$ }8 _Sorafenib + temsirolimus Yes, reduced dose
* S L3 d9 E vSorafenib + everolimus Yes, reduced dose * o( b8 j3 n! `! y! ]7 z7 ?
Sunitinib + temsirolimus† No - Q9 b- B6 g2 a: J8 Y% A1 l
Sunitinib + everolimus ? - K3 N3 w# ^$ t( m+ s8 ^
Temsirolimus + everolimus ? 0 b$ w7 A' s* F; \. L6 D9 q
————————————————————- k6 t9 K |9 ~/ q" f. ~
†Led to US FDA warning.
4 O0 q2 h# J5 b& ^% Y?: As yet unattempted combination.! M* j" `9 t) s X% h* H: `3 x
|